Agencies | Governor
Virginia Regulatory Town Hall
Department of Health Professions
Board of Pharmacy
Regulations Governing Collaborative Practice Agreements [18 VAC 110 ‑ 40]
This action is exempt from the executive branch review process.
Implementaton of 2020 legislation
General Information
Action Summary The action will amend the requirements for documented informed consent by a patient for participation in a collaborative practice agreement between a prescriber and a pharmacist. The amendment will conform to changes made in HB1506 of the 2020 General Assembly that specifies a patient must opt out of participation rather than signing a document for consent to such an agreement.
Chapters Affected Only affects this chapter.
Exempt from APA Yes, this action is exempt from Article II of the APA and executive branch review.
Exempt Citation: ยง 2.2-4006 (A) (4)(a)
RIS Project Yes  [006506]
Associated Mandates Collaborative practice agreements
New Periodic Review This action will be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
9078 Final Stage complete. This regulation became effective on 11/25/2020.
Contact Information
Name / Title: Caroline Juran, RPh  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
Email Address:
Phone: (804)367-4456    FAX: (804)527-4472    TDD: ()-

This person is the primary contact for this chapter.